Patent US4297344A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4297344A Expired / Lapsed US ⏱️ 0.0 years remaining

Blood coagulation factors and process for their manufacture

Assignee: Centeon Pharma GmbH
•
Filing: 1980-04-23
•
Granted: 1981-10-27
•
Expires: 2000-04-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for stabilizing the coagulation factors II, VIII, XIII, antithrombin III and plasminogen against heat is described. The preparations obtained according to this process are practically free from coagulable fibrinogen.

Inventors

  • 👤 Horst Schwinn
  • 👤 Norbert Heimburger
  • 👤 Gerhardt Kumpe
  • 👤 Bernd Herchenhan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 23:37
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/10; C12N9/1025; C12N9/104; C12N9/1044; A; A61; A61K; A61K31/00; A61K31/13; A61K31/14; A61K35/00; A61K35/12; A61K35/14; A61K38/00; A61K38/005; A61K38/16; A61K38/43; A61K38/46; A61K38/48; A61L; A61L2/00; A61L2/02; A61L2/04; C07; C07K; C07K14/00; C07K14/435; C07K14/745; C07K14/75; C07K14/755; C07K14/81; C07K14/8107; C07K14/811; C07K14/8121; C07K14/8128; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6429; C12N9/6435; C12Y; C12Y304/00; C12Y304/21; C12Y304/21005; C12Y304/21007; A61L2103/00; A61L2103/05; A61L2103/09; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83; Y10S530/831; Y10S530/85; Y10S530/851

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 88 words
A method for stabilizing against heat an aqueous solution containing at least one member selected from the group consisting of coagulation factors II, VIII, XIII, antithrombin III, and plasminogen, which method comprises adding to said solution from 1.0 to 3.0 mols per liter of at least one amino acid selected from the group consisting of glycine, α- and β-alanine, hydroxyproline, glutamine, and α-, β-, and γ-aminobutyric acid and from 20 to 60 w/w percent of a carbohydrate selected from the group consisting of monosaccharides, oligosaccharides, and sugar alcohols.
Claim 2
Independent Claim 88 words
A method for stabilizing against heat an aqueous solution containing at least one member selected from the group consisting of coagulation factors II, VIII, XIII, antithrombin III, and plasminogen, which method comprises adding to said solution from 1.0 to 3.0 mols per liter of at least one amino acid selected from the group consisting of glycine, α- and β-alanine, hydroxyproline, glutamine, and α-, β-, and γ-aminobutyric acid and from 20 to 60 w/w percent of a carbohydrate selected from the group consisting of monosaccharides, oligosaccharides, and sugar alcohols.
Claim 3
Dependent Claim 17 words
A method as in claim 1 wherein said amino acid is glycine and said carbohydrate is saccharose.
Claim 4
Independent Claim 154 words
A method for making a hepatitis-safe preparation of at least one member selected from the group consisting of coagulation factors II, VIII, XIII, antithrombin III, and plasminogen, which method comprises first stabilizing against heat an aqueous solution containing at least one of said members by adding to said solution from 1.0 to 3.0 mols per liter of at least one amino acid selected from the group consisting of glycine, α- and β-alanine, hydroxyproline, glutamine, and α-, β-, and γ-aminobutyric acid and from 20 to 60 w/w percent of a carbohydrate selected from the group consisting of monosaccharides, oligosaccharides, and sugar alcohols, then heating the resulting heat-stabilized aqueous solution at a temperature from 30° C. to 100° C. for a period of time from one minute to 48 hours at a pH from 6.5 to 8.0, whereby hepatitis virus present in said solution is inactivated, and then recovering at least one member from said solution.
Claim 5
Independent Claim 154 words
A method for making a hepatitis-safe preparation of at least one member selected from the group consisting of coagulation factors II, VIII, XIII, antithrombin III, and plasminogen, which method comprises first stabilizing against heat an aqueous solution containing at least one of said members by adding to said solution from 1.0 to 3.0 mols per liter of at least one amino acid selected from the group consisting of glycine, α- and β-alanine, hydroxyproline, glutamine, and α-, β-, and γ-aminobutyric acid and from 20 to 60 w/w percent of a carbohydrate selected from the group consisting of monosaccharides, oligosaccharides, and sugar alcohols, then heating the resulting heat-stabilized aqueous solution at a temperature from 30° C. to 100° C. for a period of time from one minute to 48 hours at a pH from 6.5 to 8.0, whereby hepatitis virus present in said solution is inactivated, and then recovering at least one member from said solution.
Claim 6
Dependent Claim 35 words
A method as in claim 3 wherein said amino acid is glycine, said carbohydrate is saccharose, and said heat-stabilized solution is heated at a temperature from 60° C. to 100° C. for approximately 10 hours.

References Cited (Backward Citations)

US3682881A Cited
DE2057401C3 Cited
US3732146A Cited
DE2243688A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-26 1985-04-27 1985-10-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-26 1989-04-27 1989-10-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-26 1993-04-27 1993-10-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag